NM_000321.3:c.500+23T>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000321.3(RB1):c.500+23T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.974 in 1,606,016 control chromosomes in the GnomAD database, including 762,473 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.93 ( 66838 hom., cov: 31)
Exomes 𝑓: 0.98 ( 695635 hom. )
Consequence
RB1
NM_000321.3 intron
NM_000321.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.319
Publications
16 publications found
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
RB1 Gene-Disease associations (from GenCC):
- hereditary retinoblastomaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- retinoblastomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- melanomaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 13-48345222-T-G is Benign according to our data. Variant chr13-48345222-T-G is described in ClinVar as Benign. ClinVar VariationId is 255825.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.979 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RB1 | NM_000321.3 | c.500+23T>G | intron_variant | Intron 4 of 26 | ENST00000267163.6 | NP_000312.2 | ||
| RB1 | NM_001407165.1 | c.500+23T>G | intron_variant | Intron 4 of 26 | NP_001394094.1 | |||
| RB1 | NM_001407166.1 | c.500+23T>G | intron_variant | Intron 4 of 16 | NP_001394095.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.934 AC: 142083AN: 152050Hom.: 66798 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
142083
AN:
152050
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.963 AC: 239336AN: 248654 AF XY: 0.964 show subpopulations
GnomAD2 exomes
AF:
AC:
239336
AN:
248654
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.978 AC: 1421424AN: 1453848Hom.: 695635 Cov.: 33 AF XY: 0.977 AC XY: 706735AN XY: 723694 show subpopulations
GnomAD4 exome
AF:
AC:
1421424
AN:
1453848
Hom.:
Cov.:
33
AF XY:
AC XY:
706735
AN XY:
723694
show subpopulations
African (AFR)
AF:
AC:
27160
AN:
33346
American (AMR)
AF:
AC:
42649
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
AC:
24321
AN:
26048
East Asian (EAS)
AF:
AC:
39395
AN:
39466
South Asian (SAS)
AF:
AC:
80376
AN:
86048
European-Finnish (FIN)
AF:
AC:
50322
AN:
50430
Middle Eastern (MID)
AF:
AC:
5224
AN:
5640
European-Non Finnish (NFE)
AF:
AC:
1093908
AN:
1108034
Other (OTH)
AF:
AC:
58069
AN:
60164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1371
2742
4113
5484
6855
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21568
43136
64704
86272
107840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.934 AC: 142184AN: 152168Hom.: 66838 Cov.: 31 AF XY: 0.936 AC XY: 69631AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
142184
AN:
152168
Hom.:
Cov.:
31
AF XY:
AC XY:
69631
AN XY:
74390
show subpopulations
African (AFR)
AF:
AC:
34084
AN:
41486
American (AMR)
AF:
AC:
14434
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
3254
AN:
3470
East Asian (EAS)
AF:
AC:
5162
AN:
5178
South Asian (SAS)
AF:
AC:
4502
AN:
4824
European-Finnish (FIN)
AF:
AC:
10589
AN:
10602
Middle Eastern (MID)
AF:
AC:
276
AN:
294
European-Non Finnish (NFE)
AF:
AC:
66977
AN:
67990
Other (OTH)
AF:
AC:
1996
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
420
839
1259
1678
2098
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3304
AN:
3462
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Retinoblastoma Benign:2
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.